Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

KvLQT1 Potassium Channel but Not IsK Is the Molecular Target fortrans-6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane

Gildas Loussouarn, Flavien Charpentier, Raha Mohammad-Panah, Karl Kunzelmann, Isabelle Baró and Denis Escande
Molecular Pharmacology December 1997, 52 (6) 1131-1136; DOI: https://doi.org/10.1124/mol.52.6.1131
Gildas Loussouarn
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flavien Charpentier
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raha Mohammad-Panah
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Kunzelmann
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Baró
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Escande
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 52 no. 6 1131-1136
DOI 
https://doi.org/10.1124/mol.52.6.1131
PubMed 
9396783

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 13, 1997
  • Accepted August 29, 1997
  • Published online December 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Gildas Loussouarn1,
  2. Flavien Charpentier1,
  3. Raha Mohammad-Panah1,
  4. Karl Kunzelmann2,
  5. Isabelle Baró1, and
  6. Denis Escande1
  1. 1Laboratoire de Physiopathologie et de Pharmacologie Cellulaires et Moléculaires, Institut National de la Santé et de la Recherche Médicale CJF96–01, Hôpital Hotel-Dieu, Nantes, France (G.L., F.C., R.M-P, I.B., D.E.), and 2Institute of Physiology, Albert-Ludwigs-Universität, Freiburg, Germany (K.K.)
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 1999 to June 2022

AbstractFullPdf
Jan 1999031
Feb 1999011
Mar 1999383
Apr 1999073
May 1999112
Jul 1999100
Aug 1999154
Sep 1999130
Oct 1999042
Nov 1999083
Dec 1999094
Jan 2000186
Feb 2000010
Mar 2000036
Apr 2000031
May 2000046
Jun 2000133
Jul 2000049
Aug 2000024
Sep 2000121
Oct 2000114
Nov 2000234
Dec 20002158
Jan 20016106
Feb 2001032
Mar 2001225
Apr 2001127
May 20010613
Jun 2001031
Jul 2001057
Aug 2001120
Sep 2001025
Oct 2001055
Nov 2001042
Dec 2001113
Jan 2002032
Feb 2002012
Mar 2002053
Apr 2002022
May 2002054
Jun 2002022
Jul 2002012
Aug 2002233
Sep 2002011
Oct 2002135
Nov 2002133
Dec 2002056
Jan 2003054
Feb 2003054
Mar 20030510
Apr 2003051
May 2003023
Jun 2003367
Jul 20035103
Aug 200310121
Sep 2003192911
Oct 20039136
Nov 200313208
Dec 200316238
Jan 2004142210
Feb 200410202
Mar 200413191
Apr 20048123
May 20049133
Jun 200418265
Jul 200416140
Aug 20048199
Sep 200412280
Oct 200412258
Nov 200410150
Dec 200413243
Jan 200515144
Feb 200510191
Mar 200511140
Apr 20051123
May 2005691
Jun 20058123
Jul 20055127
Aug 2005270
Sep 20051102
Oct 200510154
Nov 2005490
Dec 2005495
Jan 20063103
Feb 20065123
Mar 2006352
Apr 2006132
May 2006140
Jun 2006121
Jul 2006240
Aug 2006243
Sep 2006244
Oct 2006243
Nov 2006282
Dec 2006173
Jan 2007172
Feb 2007362
Mar 2007597
Apr 20073117
May 2007493
Jun 2007271
Jul 2007031
Aug 2007260
Sep 2007231
Oct 2007242
Nov 2007580
Dec 2007052
Jan 2008054
Feb 2008037
Mar 2008153
Apr 2008643
May 2008163
Jun 2008551
Jul 20081134
Aug 2008232
Sep 20082833
Oct 2008643
Nov 2008177
Dec 2008014
Jan 2009143
Feb 2009111
Mar 2009187
Apr 2009012
May 2009141
Jun 2009221
Jul 2009152
Aug 2009363
Sep 2009821
Oct 2009421
Nov 2009243
Dec 2009352
Jan 2010101
Feb 20101543
Mar 2010217
Apr 2010511
May 20101133
Jun 2010165
Jul 2010541
Aug 2010171
Sep 2010362
Oct 2010486
Nov 2010125
Dec 2010126
Jan 20111075
Feb 2011432
Mar 2011634
Apr 20111105
May 2011563
Jun 2011144
Jul 2011425
Aug 2011738
Sep 2011499
Oct 2011464
Nov 20114136
Dec 2011466
Jan 2012235
Feb 2012102
Mar 2012816
Apr 2012407
May 2012734
Jun 2012522
Jul 2012828
Aug 2012341
Sep 2012212
Oct 20129313
Nov 2012444
Dec 201210105
Jan 201310166
Feb 2013863
Mar 2013881
Apr 2013685
May 2013447
Jun 2013354
Jul 2013312
Aug 2013300
Sep 2013611
Oct 20139124
Nov 2013513
Dec 2013600
Jan 2014213
Feb 2014402
Mar 2014011
Apr 2014332
May 2014413
Jun 2014321
Jul 2014330
Aug 201451215
Sep 2014114
Oct 2014621
Nov 2014734
Dec 2014486
Jan 2015390
Feb 20153101
Mar 20154131
Apr 20150221
May 20159201
Jun 20156174
Jul 20153746
Aug 201513641
Sep 20153554
Oct 20153350
Nov 2015331
Dec 2015332
Jan 2016565
Feb 201639101
Mar 201615109
Apr 2016281
May 2016693
Jun 2016416
Jul 20162517
Aug 2016379
Sep 20162312
Oct 2016234
Nov 2016225
Dec 2016188
Jan 2017159
Feb 20170312
Mar 2017053
Apr 2017033
May 2017062
Jun 20170103
Jul 2017264
Aug 2017174
Sep 2017025
Oct 20170133
Nov 20170104
Dec 2017062
Jan 20180203
Feb 2018195
Mar 2018153
Apr 20181123
May 20183163
Jun 20180112
Jul 2018050
Aug 2018046
Sep 2018082
Oct 2018194
Nov 2018032
Dec 2018611
Jan 20191722
Feb 20191000
Mar 20192512
Apr 2019821
May 2019600
Jun 2019802
Jul 2019400
Aug 201952721
Sep 201958282
Oct 2019611
Nov 20191811
Dec 20191911
Jan 20202000
Feb 20201400
Mar 20202811
Apr 2020800
May 2020311
Jun 2020330
Jul 2020400
Aug 2020100
Sep 2020611
Oct 2020700
Nov 20201100
Dec 20201300
Jan 2021520
Feb 2021631
Mar 2021710
Apr 20212163
May 20212732
Jun 2021420
Jul 2021520
Aug 2021410
Sep 2021220
Oct 2021320
Nov 20211410
Dec 2021510
Jan 20221110
Feb 2022410
Mar 20222710
Apr 20223411
May 2022210
Jun 20221210

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (6)
Molecular Pharmacology
Vol. 52, Issue 6
1 Dec 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
KvLQT1 Potassium Channel but Not IsK Is the Molecular Target fortrans-6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

KvLQT1 Potassium Channel but Not IsK Is the Molecular Target fortrans-6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane

Gildas Loussouarn, Flavien Charpentier, Raha Mohammad-Panah, Karl Kunzelmann, Isabelle Baró and Denis Escande
Molecular Pharmacology December 1, 1997, 52 (6) 1131-1136; DOI: https://doi.org/10.1124/mol.52.6.1131

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

KvLQT1 Potassium Channel but Not IsK Is the Molecular Target fortrans-6-Cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane

Gildas Loussouarn, Flavien Charpentier, Raha Mohammad-Panah, Karl Kunzelmann, Isabelle Baró and Denis Escande
Molecular Pharmacology December 1, 1997, 52 (6) 1131-1136; DOI: https://doi.org/10.1124/mol.52.6.1131
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics